Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Research from University of Amsterdam provides new data on adenocarcinoma
September 23rd, 2008
"Lymphatic dissemination is an important predictor of survival in patients with adenocarcinoma of the ampulla of Vater. The incidence and clinical consequences of extracapsular lymph node involvement (LNI) in patients who undergo resection are unknown," researchers in Netherlands report. "In a consecutive series of 160 patients with adenocarcinoma of the ampulla of Vater, 75 (46.9 per cent) had positive lymph nodes (NI). The relation of extracapsular LNI with tumour stage and number of positive nodes was evaluated and its prognostic significance analysed. Extracapsular LNI was identified in 44 (59 per cent) of the 75 patients. Median overall survival was 30 and 18...
Source: Cancer Weekly (2008-09-23)
|
